These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 122616)

  • 1. Differential susceptibility of endocrine tissues to humoral immunity.
    Naji A; Barker CF
    Surg Forum; 1978; 29():349-51. PubMed ID: 122616
    [No Abstract]   [Full Text] [Related]  

  • 2. Relative vulnerability of isolated pancreatic islets, parathyroid, and skin allografts to cellular and humoral immunity.
    Naji A; Barker CF; Silvers WK
    Transplant Proc; 1979 Mar; 11(1):560-2. PubMed ID: 109967
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of removing passenger cells on the fate of skin and parathyroid allografts. Evidence for major histocompatibility complex restriction in transplantation immunity.
    Silvers WK; Fleming HL; Naji A; Barker CF
    Diabetes; 1982 Aug; 31 Suppl 4():60-2. PubMed ID: 6819966
    [No Abstract]   [Full Text] [Related]  

  • 4. Injection of bone marrow cells into the thymus to achieve tolerance in an islet xenotransplant (human-to-rat) model.
    Dellagiacoma G; Rossi M; Castagna MT; Radin S; Vecchioni R
    Transplant Proc; 1994 Jun; 26(3):1114-5. PubMed ID: 8029850
    [No Abstract]   [Full Text] [Related]  

  • 5. Intrathymic transplantation as a model for tolerance.
    Barker CF; Posselt AM; Odorico JS; Markmann JF; Naji A
    Adv Nephrol Necker Hosp; 1993; 22():387-400. PubMed ID: 8427065
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrathymic transplantation of rat perinatal islets, devoid of class II bearing cells, does not induce donor-specific tolerance.
    Moore WV; Moyer C; Pan F; Donaldson D; Forster J; Kover K
    Transplant Proc; 1995 Dec; 27(6):3200. PubMed ID: 8539912
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of rat islet tolerance with bone marrow transplantation using a non-myeloablative procedure II: failure despite the presence of lymphocyte microchimerism in the fully allogeneic Lewis/Brown-Norway model.
    Kriz J; Saudek F; Girman P; Novota P
    Int J Tissue React; 2004; 26(3-4):75-83. PubMed ID: 15648439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B cell response to portal or systemic endocrine graft drainage in heterotopic pancreas transplantation in the rat.
    Limmer J; Behr A; Petzold K; Beischer W; Beger HG
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1015-6. PubMed ID: 3152621
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of tolerance using ultraviolet-irradiated cells.
    Agostino M; Prowse SJ; Lafferty KJ
    Transplant Proc; 1984 Aug; 16(4):959-60. PubMed ID: 6431670
    [No Abstract]   [Full Text] [Related]  

  • 10. Prolonged survival of endocrine allografts with preoperative cyclosporine A.
    Gebel HM; Bloom A; McErlean J; Leifheit AK; Economou S
    Transplant Proc; 1987 Feb; 19(1 Pt 2):946-9. PubMed ID: 3103290
    [No Abstract]   [Full Text] [Related]  

  • 11. Intrathymic inoculation of donor bone marrow cells prior to xenotransplantation of pig pancreatic islets into diabetic rats.
    de Villa V; Balén E; Torramadé J; Regueira F; Diez-Caballero A; Sierra A; Sáez E; Pardo F; Hernández JL; Cienfuegos JA
    Transplant Proc; 1994 Dec; 26(6):3455-6. PubMed ID: 7998219
    [No Abstract]   [Full Text] [Related]  

  • 12. Radiation-immunological problems and experimental application of tissue transplantation including bone marrow.
    Szirmai E; Hajdukovic S
    Haematologica; 1967; 52(4):321-43. PubMed ID: 4976388
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential susceptibility of segmental and isolated islet allografts of rat pancreas to rejection and enhancement.
    Reckard CR; Stuart FP; Clayman JL; Buckingham F; Schulak JA
    Transplant Proc; 1981 Mar; 13(1 Pt 2):819-22. PubMed ID: 6791337
    [No Abstract]   [Full Text] [Related]  

  • 14. Endocrine transplantation; progress.
    Reemtsma K; Weber CJ
    N Y State J Med; 1981 Oct; 81(11):1613-6. PubMed ID: 6793947
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance of islet allografts induced by orthotopic liver transplantation.
    Sawada T; Asanuma Y; Furuya T; Saito K; Koyama K
    J Surg Res; 1999 Aug; 85(2):209-16. PubMed ID: 10423321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of diabetes incidence by intrathymic islet isografting in newborn NOD mice.
    Nomura Y; Stein E; Mullen Y
    Transplant Proc; 1992 Dec; 24(6):2903. PubMed ID: 1465992
    [No Abstract]   [Full Text] [Related]  

  • 17. [Anti-lymphocyte serum, bone marrow and immunological tolerance in the young dog].
    Otte H; Grosjean O
    C R Seances Soc Biol Fil; 1967; 161(4):959-62. PubMed ID: 4229530
    [No Abstract]   [Full Text] [Related]  

  • 18. Vulnerability of pancreatic islets to immune cells and serum.
    Naji A; Reckard CR; Ziegler MM; Barker CF
    Surg Forum; 1975; 26():459-61. PubMed ID: 814643
    [No Abstract]   [Full Text] [Related]  

  • 19. [Human cell transplantation].
    Hayashi H; Mito M
    Hum Cell; 1988 Jun; 1(2):129-39. PubMed ID: 2979192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of H-Y-incompatible endocrine grafts in mice and rats.
    Naji A; Frangipane L; Barker CF; Silvers WK
    Transplantation; 1981 Feb; 31(2):145-7. PubMed ID: 6454992
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.